CD1D and neoplasm: This mechanism ensures activation of type I NKT cells early in an ensuing inflammatory response during infection even when no microbial CD1d-presented lipids are expressed, as is the case, for example, during viral infections, and similar mechanisms may explain type I NKT cell activation in tumor immunity and autoimmune diseases (121, 122).